Connection
Jeffrey Goldstein to Recombinant Proteins
This is a "connection" page, showing publications Jeffrey Goldstein has written about Recombinant Proteins.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.071 |
|
|
|
-
Kaminsky LS, de Morais SM, Faletto MB, Dunbar DA, Goldstein JA. Correlation of human cytochrome P4502C substrate specificities with primary structure: warfarin as a probe. Mol Pharmacol. 1993 Feb; 43(2):234-9.
Score: 0.027
-
Faletto MB, Linko P, Goldstein JA. A single amino acid mutation (Ser180----Cys) determines the polymorphism in cytochrome P450g (P4502C13) by altering protein stability. J Biol Chem. 1992 Jan 25; 267(3):2032-7.
Score: 0.026
-
Karam WG, Goldstein JA, Lasker JM, Ghanayem BI. Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes. Drug Metab Dispos. 1996 Oct; 24(10):1081-7.
Score: 0.009
-
Pearce RE, Rodrigues AD, Goldstein JA, Parkinson A. Identification of the human P450 enzymes involved in lansoprazole metabolism. J Pharmacol Exp Ther. 1996 May; 277(2):805-16.
Score: 0.009